Business
-
According to MannKind Corporation, it has completely resolved arbitration initiated by a lawsuit filed by its former Senior Director – GCP – Regulatory Affairs, John Arditi, in 2010. Arditi, who had been responsible for MannKind’s… Read more . . .
-
US Patent No. 8,076,290 regarding stabilized formulations of parathyroid hormone (PTH) and PTH peptide analogs for various means of delivery, including intranasal delivery, has been awarded to Aegis Therapeutics. PTH and PTH peptide analogs such… Read more . . .
-
The United States Patent and Trademark Office has issued US Patent No. 8,071,127 regarding formulations of inhaled liposomal and free ciprofloxacin to Aradigm Corporation. The patent covers the company’s lead candidate, Pulmaquin dual release ciprofloxacin… Read more . . .
-
A report from research firm Decision Resources predicts no growth in the asthma drug market through 2020, in large part due to incursions by generics and greater competition. According to the company, “The overall asthma… Read more . . .
-
Merck and NanoBio will conduct preclinical studies to evaluate a vaccine combining Merck’s respiratory syncyctial virus (RSV) antigen with NanoBio’s NanoStat adjuvant. NanoBio has already conducted studies that showed the induction of immunity by a… Read more . . .
-
Swedish pharma company Meda released a statement regarding a new patent for its Astepro nasal spray that reads in its entirety: “The United States Patent and Trademark Office (USPTO) today issued a patent related to… Read more . . .
-
Consort Medical, parent company of device developer and manufacturer Bespak, reports “strong volume growth” for Bespak’s inhaler business for the six months ending October 31, 2011. Bespak revenues were up 17% from 2010, with operating… Read more . . .
-
Acacia Research, a California company frequently described as a “patent troll,” says that it has acquired 13 patents for inhaler technology from “a major medical company.” Company CEO Paul Ryan said, “Acacia continues to increase… Read more . . .
-
Bloomberg has published an article about GSK’s overhaul of its R&D organization that describes former head of the allergic inflammation discovery performance unit Roberto Solari as “one of the casualties of the company’s new approach… Read more . . .
-
AstraZeneca has asked the New Zealand High Court to review a decision by Pharmac, the government drug purchasing agency, to reduce its subsidy for the Symbicort Turbuhaler to achieve pricing parity with GSK’s Seretide (Advair)… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK